Jointechlabs, Inc.

Jointechlabs, Inc.

Advancing Regenerative Medicine at the Point of Care | FDA-Cleared and CE-Marked Devices Transforming Patient Care

Founded 2014

Brandon, United States 8 employees Series A Total: $2.25M Biotechnology, Health Care +1

Jointechlabs, Inc., founded in 2014, is establishing itself as a leader in Biotechnology, Health Care, and Medical Devices with a robust focus on regenerative medicine solutions. The company's slogan, "Regenerative Medicine Solutions", succinctly reflects its core mission to provide cutting-edge, non-surgical therapies.

With the FDA cleared MiniTC® and the CE Mark pending Mini-Stem System™, Jointechlabs offers healthcare practitioners and hospitals innovative devices that fit seamlessly into existing infrastructures, promoting safe and cost-effective treatments. Both platforms further pave the way for advanced development in clinical therapies and 3D Bioprinting of tissues.

The company, headquartered in the United States, secured a $500.00K seed round investment on 07 October 2022 from Newchip Accelerator. This reflects investor confidence in Jointechlabs' potential to drive advancements in the regenerative medicine market.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	$250.00K	1	Newchip	01 Oct 2022
Convertible Note	$500.00K	-		01 Apr 2021
Seed	$1.50M	2	Expert DOJO, indiebio	01 Apr 2018

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

$250.00K

Newchip

01 Oct 2022

Convertible Note

$500.00K

01 Apr 2021

Seed

$1.50M

Expert DOJO, indiebio

01 Apr 2018

FAQ About Jointechlabs, Inc.

Advancing Regenerative Medicine at the Point of Care | FDA-Cleared and CE-Marked Devices Transforming Patient Care

Jointechlabs, Inc. was founded in 2014.

Jointechlabs, Inc. is headquartered in Brandon, United States.

Jointechlabs, Inc. operates in Biotechnology, Health Care and Medical Devices. Its work centres on Regenerative Medicine, Point-of-Care Therapies, FDA Cleared Devices and CE Mark Pending. Its customers include Physicians, Clinics and Patients with Joint Pain.

Jointechlabs, Inc. has a B2B2C and B2B business model. Its revenue comes from Product Sales, One Time Purchase and Usage Based.

Jointechlabs, Inc. has approximately 8 employees.

Jointechlabs, Inc. has completed 3 funding rounds, raising a total of $2.25M. The latest funding stage is Series A.

Jointechlabs, Inc. offers: Microfat Processing System, Pain Management Solutions, Orthopedic Applications, Sports Medicine Solutions, Aesthetic and Reconstructive Applications.

Top alternatives and competitors to Jointechlabs, Inc. include iTind, ZETA SURGICAL, Reliefband Technologies LLC, Pinnacle Transplant Technologies, Ceribell │ AI-Powered Point-of-Care EEG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Jointechlabs, Inc. and iTind are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Jointechlabs, Inc.

Services & Products

Target Customers

Funding Rounds & Investors (3)

Jointechlabs, Inc. Alternatives & Competitors

FAQ About Jointechlabs, Inc.